GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT)

Jingang Shen1, Xianbao Lv1, Lei Zhang2

  • 1Department of Urology, Chengwu County People's Hospital, Shandong 274200, People's Republic of China.

Abstract

Insights

The study found that GRHL2 acts as an anti-oncogene in bladder cancer, inhibiting cell proliferation and epithelial-mesenchymal transition (EMT) by targeting ZEB1. This research offers a basis for future bladder cancer studies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • GRHL2 (Grainy-like protein 2) is implicated in various cancers.
  • Understanding GRHL2's role in bladder cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the function of GRHL2 in bladder cancer.
  • To explore the relationship between GRHL2, cell proliferation, and EMT.

Main Methods:

  • Immunohistochemistry and qRT-PCR to assess GRHL2 and ZEB1 expression in tissues and cell lines.
  • Cell models with altered GRHL2 expression to evaluate proliferation, migration, invasion, and EMT.
  • Western blotting to analyze EMT markers.

Main Results:

  • GRHL2 expression is reduced in bladder cancer tissues and cell lines.
  • Downregulation of GRHL2 enhances bladder cancer cell proliferation and promotes EMT via ZEB1 upregulation.
  • ZEB1 overexpression partially counteracted GRHL2's inhibitory effects on EMT.

Conclusions:

  • GRHL2 functions as an anti-oncogene in bladder cancer, suppressing proliferation and EMT.
  • GRHL2 targets ZEB1 to exert its anti-cancer effects.
  • Findings provide a foundation for further bladder cancer research.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K